Melanotan I Read the full profile What it targets (One pigment switch (focused)) Peptide size/shape (Longer, straight-chain) Molecular weight (1,646.85 Da) Typical starting dose (0.250.5 mg/day) Typical upkeep dose (23x weekly) How long it lasts in the body (~0.5 hours) Given as a shot under the skin FDA-approved (as afamelanotide/Scenesse) Gentler, more limited side effects Melanotan II Read the full profile What it targets (Several switches (broad)) Peptide size/shape (Shorter, ring-shaped) Molecular weight (1,024.18 Da) Also affects appetite/libido Typical starting dose (0.250.5 mg/day) Typical upkeep dose (12x weekly) How long it lasts in the body (~1.5 hours) Given as a shot under the skin Our top-rated vendor Our rankings are based solely on third-party lab testing rigor, COA transparency, and pricing no paid placements, no affiliate influence
The strongest peer-reviewed human finding comes from the Astrup et al
People who have a certain type of thyroid cancer, which is medullary thyroid cancer, is very specific and it's very rare, they cannot use that, okay, it's a big no-no, Ortiz said
Product quality verification remains essential for safety
The optimized analog, compound 32 ((4S,5S)-5-(aminomethyl)-1-(2-(benzo[d] [1,3] dioxol-5-yl) ethyl)-4-(2,5-difluorophenyl) piperidin-2-one), was found to exhibit high levels of DPP-4 selectivity and potency in vitro